Frank W. Byers

856 citations

21 papers · 416 indexed · h-index 14

Co-authors: J. Scott Daniels Craig W. Lindsley P. Jeffrey Conn Ryan D. Morrison Kyle A. Emmitte Colleen M. Niswender Andrew S. Felts Alice L. Rodriguez
Topics: Neuroscience and Neuropharmacology Research (15 papers)Receptor Mechanisms and Signaling (14 papers)Pharmacological Receptor Mechanisms and Effects (6 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Pharmacology
Journals: Journal of Medicinal Chemistry Neuropsychopharmacology Drug Metabolism and Disposition
Partner nations: United States Belgium

In The Last Decade

Frank W. Byers

21 papers receiving 414 citations

Peers

Countries citing papers authored by Frank W. Byers

Since Specialization

Citations

This map shows the geographic impact of Frank W. Byers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank W. Byers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank W. Byers more than expected).

Fields of papers citing papers by Frank W. Byers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank W. Byers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank W. Byers. The network helps show where Frank W. Byers may publish in the future.

Co-authorship network of co-authors of Frank W. Byers

This figure shows the co-authorship network connecting the top 25 collaborators of Frank W. Byers. A scholar is included among the top collaborators of Frank W. Byers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank W. Byers. Frank W. Byers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5 2018 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Felts,Alice L. Rodriguez,Ryan D. Morrison,Anna L. Blobaum,Frank W. Byers,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	1
2	Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides 2017 ·Bioorganic & Medicinal Chemistry Letters ·James C. Tarr,Michael R. Wood,Meredith J. Noetzel,(unknown),Rebecca L. Weiner,Alice L. Rodriguez,Atin Lamsal,Frank W. Byers,Sichen Chang,Hyekyung P. Cho,Carrie K. Jones,Colleen M. Niswender,Michael W. Wood,Nicholas J. Brandon,Mark E. Duggan,P. Jeffrey Conn,Thomas M. Bridges,Craig W. Lindsley	16
3	Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5 2017 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Felts,Alice L. Rodriguez,Ryan D. Morrison,(unknown),Daryl F. Venable,Anna L. Blobaum,Frank W. Byers,(unknown),J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	10
4	Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides 2017 ·Bioorganic & Medicinal Chemistry Letters ·James C. Tarr,Michael R. Wood,Meredith J. Noetzel,Bruce J. Melancon,Atin Lamsal,Vincent B. Luscombe,Alice L. Rodriguez,Frank W. Byers,Sichen Chang,Hyekyung P. Cho,Darren W. Engers,Carrie K. Jones,Colleen M. Niswender,Michael W. Wood,Nicholas J. Brandon,Mark E. Duggan,P. Jeffrey Conn,Thomas M. Bridges,Craig W. Lindsley	11
5	Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity 2016 ·Drug Metabolism and Disposition ·(unknown),(unknown),Frank W. Byers,Craig W. Lindsley,Kyle A. Emmitte,J. Scott Daniels	18
6	N-Alkylpyrido[1′,2′:1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents 2016 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Felts,Alice L. Rodriguez,Ryan D. Morrison,Daryl F. Venable,Anna L. Blobaum,Frank W. Byers,J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	6
7	A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo 2015 ·Drug Metabolism and Disposition ·Anna L. Blobaum,Frank W. Byers,Thomas M. Bridges,Charles W. Locuson,P. Jeffrey Conn,Craig W. Lindsley,J. Scott Daniels	8
8	Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects 2015 ·Neuropsychopharmacology ·Robert W. Gould,(unknown),Michael Bubser,Max E. Joffe,Michael T. Nedelcovych,Analisa D. Thompson,Hilary Highfield Nickols,(unknown),Xiaoyan Zhan,Andrew S. Felts,Alice L. Rodriguez,Ryan D. Morrison,Frank W. Byers,Jerri M. Rook,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Kyle A. Emmitte,Craig W. Lindsley,Carrie K. Jones	36
9	Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2 2015 ·Journal of Medicinal Chemistry ·Andrew S. Felts,Alice L. Rodriguez,(unknown),Julie L. Engers,Ryan D. Morrison,Frank W. Byers,Anna L. Blobaum,Charles W. Locuson,Sichen Chang,Daryl F. Venable,Colleen M. Niswender,J. Scott Daniels,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	29
10	Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents 2015 ·Journal of Medicinal Chemistry ·Julie L. Engers,Alice L. Rodriguez,Leah C. Konkol,Ryan D. Morrison,Analisa D. Thompson,Frank W. Byers,Anna L. Blobaum,Sichen Chang,Daryl F. Venable,(unknown),Colleen M. Niswender,J. Scott Daniels,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	55
11	Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu₁), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu₁ Receptors Found in Schizophrenics 2015 ·Journal of Medicinal Chemistry ·Pedro M. García-Barrantes,Hyekyung P. Cho,Colleen M. Niswender,Frank W. Byers,Charles W. Locuson,Anna L. Blobaum,Zixiu Xiang,Jerri M. Rook,P. Jeffrey Conn,Craig W. Lindsley	17
12	Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)‐Selective M₅‐Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe 2014 ·ChemMedChem ·Patrick R. Gentry,Masaya Kokubo,Thomas M. Bridges,Hyekyung P. Cho,Emery Smith,Peter Chase,Peter Hodder,Thomas J. Utley,(unknown),Frank W. Byers,Colleen M. Niswender,Ryan D. Morrison,J. Scott Daniels,Michael R. Wood,P. Jeffrey Conn,Craig W. Lindsley	21
13	Discovery of VU0431316: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Alice L. Rodriguez,Andrew S. Felts,Ryan D. Morrison,Daryl F. Venable,Anna L. Blobaum,Frank W. Byers,(unknown),J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	8
14	Further optimization of the M5 NAM MLPCN probe ML375: Tactics and challenges 2014 ·Bioorganic & Medicinal Chemistry Letters ·H. Kurata,Patrick R. Gentry,Masaya Kokubo,Hyekyung P. Cho,Thomas M. Bridges,Colleen M. Niswender,Frank W. Byers,Michael R. Wood,J. Scott Daniels,P. Jeffrey Conn,Craig W. Lindsley	17
15	Use of a novel rapid and resource‐efficient cassette dosing approach to determine the pharmacokinetics and CNS distribution of small molecule 7‐transmembrane receptor allosteric modulators in rat 2014 ·Pharmacology Research & Perspectives ·Thomas M. Bridges,Ryan D. Morrison,Frank W. Byers,Shuanghui Luo,J. Scott Daniels	22
16	Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety 2013 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Felts,Alice L. Rodriguez,Ryan D. Morrison,Daryl F. Venable,Jason Manka,(unknown),Anna L. Blobaum,Frank W. Byers,J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	27
17	Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu₅: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction 2013 ·ACS Chemical Neuroscience ·(unknown),Andrew S. Felts,Alice L. Rodriguez,Daryl F. Venable,Ryan D. Morrison,Frank W. Byers,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Carrie K. Jones,Kyle A. Emmitte	14
18	N-Acyl-N′-arylpiperazines as negative allosteric modulators of mGlu1: Identification of VU0469650, a potent and selective tool compound with CNS exposure in rats 2013 ·Bioorganic & Medicinal Chemistry Letters ·Kimberly M. Lovell,Andrew S. Felts,Alice L. Rodriguez,Daryl F. Venable,Hyekyung P. Cho,Ryan D. Morrison,Frank W. Byers,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte	13
19	Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu₃ Selective and CNS Penetrant Negative Allosteric Modulator (NAM) 2013 ·Journal of Medicinal Chemistry ·Cody J. Wenthur,Ryan D. Morrison,Andrew S. Felts,(unknown),Julie L. Engers,Frank W. Byers,J. Scott Daniels,Kyle A. Emmitte,P. Jeffrey Conn,Craig W. Lindsley	47
20	Heterotropic Activation of the Midazolam Hydroxylase Activity of CYP3A by a Positive Allosteric Modulator of mGlu5: In Vitro to In Vivo Translation and Potential Impact on Clinically Relevant Drug-Drug Interactions 2013 ·Drug Metabolism and Disposition ·Anna L. Blobaum,Thomas M. Bridges,Frank W. Byers,Mark Turlington,Margrith E. Mattmann,Ryan D. Morrison,Claire Mackie,Hilde Lavreysen,(unknown),Gregor J. Macdonald,Thomas Steckler,Carrie K. Jones,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Shaun R. Stauffer,J. Scott Daniels	16

About Frank W. Byers

Frank W. Byers is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Pharmacology, having authored 21 papers that have together received 416 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (15 papers), Receptor Mechanisms and Signaling (14 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (283 citations), Biological Psychiatry (30 citations) and Pharmacology (42 citations). Frank W. Byers has collaborated with scholars based in United States and Belgium. Frequent co-authors include J. Scott Daniels, Craig W. Lindsley, P. Jeffrey Conn, Ryan D. Morrison, Kyle A. Emmitte, Colleen M. Niswender, Andrew S. Felts, Alice L. Rodriguez, Carrie K. Jones and Anna L. Blobaum. Their work appears in journals such as Journal of Medicinal Chemistry, Neuropsychopharmacology and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact